| Insulin and hyperandrogenism in women with polycystic ovary syndrome CG Baptiste, MC Battista, A Trottier, JP Baillargeon The Journal of steroid biochemistry and molecular biology 122 (1-3), 42-52, 2010 | 457 | 2010 |
| Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis JP Baillargeon, DK McClish, PA Essah, JE Nestler The Journal of Clinical Endocrinology & Metabolism 90 (7), 3863-3870, 2005 | 450 | 2005 |
| Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity JP Baillargeon, DJ Jakubowicz, MJ Iuorno, S Jakubowicz, JE Nestler Fertility and sterility 82 (4), 893-902, 2004 | 395 | 2004 |
| Basic infertility including polycystic ovary syndrome M Brassard, Y AinMelk, JP Baillargeon Medical Clinics of North America 92 (5), 1163-1192, 2008 | 308 | 2008 |
| Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases SM Ruchat, AA Houde, G Voisin, J St-Pierre, P Perron, JP Baillargeon, ... Epigenetics 8 (9), 935-943, 2013 | 300 | 2013 |
| A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills E Diamanti-Kandarakis, JP Baillargeon, MJ Iuorno, DJ Jakubowicz, ... J Clin Endocrinol Metab 88 (5), 1927-1932, 2003 | 295 | 2003 |
| Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? JP Baillargeon, JE Nestler The Journal of Clinical Endocrinology & Metabolism 91 (1), 22-24, 2006 | 267 | 2006 |
| Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction E Papaleo, V Unfer, JP Baillargeon, L De Santis, F Fusi, C Brigante, ... Gynecological Endocrinology 23 (12), 700-703, 2007 | 256 | 2007 |
| Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome MJ Iuorno, DJ Jakubowicz, JP Baillargeon, P Dillon, RD Gunn, G Allan, ... Endocrine Practice 8 (6), 417-423, 2002 | 255 | 2002 |
| Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial E Papaleo, V Unfer, JP Baillargeon, F Fusi, F Occhi, L De Santis Fertility and sterility 91 (5), 1750-1754, 2009 | 247 | 2009 |
| Reproducibility of the 6-minute walk test in obese adults K Beriault, AC Carpentier, C Gagnon, J Ménard, JP Baillargeon, ... International journal of sports medicine 30 (10), 725-727, 2009 | 225 | 2009 |
| Altered D-Chiro-Inositol Urinary Clearance in Women With Polycystic Ovary Syndrome JP Baillargeon, E Diamanti-Kandarakis, RE Ostlund Jr, T Apridonidze, ... Diabetes care 29 (2), 300-305, 2006 | 217 | 2006 |
| Insulin sensitizers for polycystic ovary syndrome JP Baillargeon, MJ Iuorno, JE Nestler Clinical obstetrics and gynecology 46 (2), 325-340, 2003 | 206 | 2003 |
| Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS V Unfer, G Carlomagno, E Papaleo, S Vailati, M Candiani, JP Baillargeon Reproductive Sciences 21 (7), 854-858, 2014 | 161 | 2014 |
| Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy DJ Jakubowicz, PA Essah, M Seppälä, S Jakubowicz, JP Baillargeon, ... The Journal of Clinical Endocrinology & Metabolism 89 (2), 833-839, 2004 | 158 | 2004 |
| Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis A Baillot, AJ Romain, K Boisvert-Vigneault, M Audet, JP Baillargeon, ... PLoS One 10 (4), e0119017, 2015 | 153 | 2015 |
| Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity JP Baillargeon, A Carpentier Fertility and sterility 88 (4), 886-893, 2007 | 151 | 2007 |
| Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome KI Cheang, JP Baillargeon, PA Essah, RE Ostlund Jr, T Apridonize, ... Metabolism 57 (10), 1390-1397, 2008 | 149 | 2008 |
| Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity C Roberge, AC Carpentier, MF Langlois, JP Baillargeon, JL Ardilouze, ... American Journal of Physiology-Endocrinology and Metabolism 293 (6), E1465-E1478, 2007 | 137 | 2007 |
| Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus AA Khan, CA Koch, S Van Uum, JP Baillargeon, J Bollerslev, ML Brandi, ... European Journal of Endocrinology 180 (3), P1-P22, 2019 | 127 | 2019 |
André CarpentierProfesseur de médecine, Université de SherbrookeVerified email at usherbrooke.ca
